EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

ASSESSMENT OF ADVERSE EVENTS IN CANCER PATIENTS UNDERGOING RADIATION THERAPY - LONGITUDINAL OBSERVATIONAL STUDY

Raghavendra D Sagar, Saikrishna Patil, Dr. Manjula G, Madiwalaya S Ganachari

Genetics and Molecular Research · 01.06.2026

DOI: 10.4238/pe74jj60 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genetics and Molecular Research, online erschienen am 01.06.2026. Verfasst von Raghavendra D Sagar und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Radiation therapy is a cornerstone in cancer treatment but is often accompanied by radiation-related adverse events (RRAEs), which can impair quality of life, particularly in settings with limited technological advancement. This study aimed to evaluate the frequency and severity of RRAEs in cancer patients undergoing radiotherapy or chemoradiotherapy.

Methods

This prospective observational study was conducted over six months in a tertiary cancer care hospital, KLE’s Cancer Hospital, Belagavi. A total of 93 patients receiving radiotherapy or Concurrent chemoradiotherapy were monitored for RRAEs by a radiation oncologist along with clinical pharmacists, using Radiation Therapy Oncology Group (RTOG) criteria, and were documented.

Results

Major RRAEs included radiation dermatitis (59.1%), oral mucositis (56.9%), neutropenia (92.47%), haemoglobin toxicity (93.5%), and radiation enteritis (63.4%). Symptoms peaked during the fifth week. Post-treatment issues like nausea and fatigue increased. Multiple concurrent toxicities were common.

Conclusion

RRAEs are frequent and can significantly impact quality of life and also therapy outcomes. Involving clinical pharmacists in monitoring and reporting can help mitigate risks. Continuous monitoring during and after treatment are recommended. Clinical pharmacists can play a crucial role in detecting, reporting, and managing these adverse effects in collaboration with radiation oncologists. Implementing structured reporting systems and preventive strategies may improve patient outcomes and enhance the safety of cancer treatment.

Zitieren

APA

Sagar, R. D., Patil, S., G, D. M., & Ganachari, M. S. (2026). ASSESSMENT OF ADVERSE EVENTS IN CANCER PATIENTS UNDERGOING RADIATION THERAPY - LONGITUDINAL OBSERVATIONAL STUDY. Genetics and Molecular Research. https://doi.org/10.4238/pe74jj60

Vancouver

Sagar RD, Patil S, G DM, Ganachari MS. ASSESSMENT OF ADVERSE EVENTS IN CANCER PATIENTS UNDERGOING RADIATION THERAPY - LONGITUDINAL OBSERVATIONAL STUDY. Genetics and Molecular Research. 2026. doi:10.4238/pe74jj60

BibTeX
@article{Sagar2026,
  author = {Sagar, Raghavendra D and Patil, Saikrishna and G, Dr. Manjula and Ganachari, Madiwalaya S},
  title = {ASSESSMENT OF ADVERSE EVENTS IN CANCER PATIENTS UNDERGOING RADIATION THERAPY - LONGITUDINAL OBSERVATIONAL STUDY},
  journal = {Genetics and Molecular Research},
  year = {2026},
  doi = {10.4238/pe74jj60}
}
Kostenlos starten →